Home › Funds › Vanguard Group › RLAY
Vanguard Group position in RLAY
RELAY THERAPEUTICS INC · Health Care
Latest position (Q4 2025)9.69M sh
Reported value held$81.99M
Portfolio Weight0.00%
First reportedQ1 2021
Last changeAdd
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2021 | 4.05M | $140.05M | New |
| Q2 2021 | 4.29M | $157.10M | Add |
| Q3 2021 | 4.88M | $153.99M | Add |
| Q4 2021 | 6.20M | $190.35M | Add |
| Q1 2022 | 6.22M | $186.09M | Hold |
| Q2 2022 | 7.10M | $118.90M | Add |
| Q3 2022 | 8.36M | $187.00M | Add |
| Q4 2022 | 10.38M | $155.14M | Add |
| Q1 2023 | 10.50M | $172.93M | Add |
| Q2 2023 | 10.53M | $132.24M | Hold |
| Q3 2023 | 10.55M | $88.75M | Hold |
| Q4 2023 | 10.65M | $117.26M | Add |
| Q1 2024 | 11.82M | $98.07M | Add |
| Q2 2024 | 11.70M | $76.32M | Reduce |
| Q3 2024 | 14.46M | $102.40M | Add |
| Q4 2024 | 15.03M | $61.92M | Add |
| Q1 2025 | 12.11M | $31.72M | Reduce |
| Q2 2025 | 9.38M | $32.45M | Reduce |
| Q3 2025 | 9.40M | $49.05M | Hold |
| Q4 2025 | 9.69M | $81.99M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding RLAY
- Fidelity Management & Research (FMR) 20.11M sh · $376.26M · Q2 2026
- Casdin Capital 16.04M sh · $300.02M · Q2 2026
- BlackRock Inc 15.29M sh · $286.04M · Q2 2026
- Geode Capital Management 4.73M sh · $88.45M · Q2 2026
- Morgan Stanley 3.85M sh · $72.05M · Q2 2026
- Goldman Sachs Group 3.41M sh · $63.78M · Q2 2026
- Bank of America Corp 2.70M sh · $50.43M · Q2 2026
- Arrowstreet Capital 2.24M sh · $41.89M · Q2 2026
- Northern Trust Corp 1.95M sh · $36.55M · Q2 2026
- Franklin Resources 1.86M sh · $34.74M · Q2 2026
- Charles Schwab Investment Management 1.50M sh · $28.08M · Q2 2026